Transforming growth factor-β3 (Tgf-β3) down-regulates Tgf-β receptor type I (Tβr-I) during rescue of cranial sutures from osseous obliteration

Orthodontics and Craniofacial Research

Volumn 5, Issue 1, 2002, Pages 5-16

  Opperman, Lyne A ^a   Galanis, Victor ^a   Williams, Avery R ^a   Adab, Katayoun ^a  

^a BAYLOR COLLEGE OF DENTISTRY   (United States)

Author keywords

Cranial sutures; Craniosynostosis; Intramembranous bone; Morphogenesis; Tgf receptors

Indexed keywords

ACTIVIN RECEPTOR 1; TGF BETA TYPE I RECEPTOR; TGF-BETA TYPE I RECEPTOR; TGFB3 PROTEIN, RAT; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; TRANSFORMING GROWTH FACTOR BETA3;

ANALYSIS OF VARIANCE; ANIMAL; ARTICLE; BINDING COMPETITION; CRANIAL SUTURE; CRANIOFACIAL SYNOSTOSIS; CYTOLOGY; DOWN REGULATION; DURA MATER; IMMUNOHISTOCHEMISTRY; METABOLISM; NONPARAMETRIC TEST; ORGAN CULTURE TECHNIQUE; OSTEOBLAST; PRENATAL DEVELOPMENT; RAT; SPRAGUE DAWLEY RAT;

ACTIVIN RECEPTORS, TYPE I; ANALYSIS OF VARIANCE; ANIMALS; BINDING, COMPETITIVE; CRANIAL SUTURES; CRANIOSYNOSTOSES; DOWN-REGULATION; DURA MATER; IMMUNOHISTOCHEMISTRY; ORGAN CULTURE TECHNIQUES; OSTEOBLASTS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; STATISTICS, NONPARAMETRIC; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA3;

EID: 0036463483     PISSN: 16016335     EISSN: 16016343     Source Type: Journal    
DOI: 10.1034/j.1600-0544.2002.01179.x     Document Type: Article

References (39)

1. Carlson BM. Human Embryology and Developmental Biology. St Louis: Mosby, Inc.; 1999, p 494.
2. Bellus GA, Gaudenz K, Zackai EH, Clarke LA, Szabo J, Francomano CA, Muenke M. Identical mutations in three different fibroblast growth factor receptor genes in autosomal dominant craniosynostosis syndromes. Nat Genet 1996;14:174-6.
3. Jabs EW, Li X, Scott AF, Meyers G, Chen W, Eccles M, Mao JI, Charnas LR, Jackson CE, Jaye M. Jackson-Weiss and Crouzon syndromes are allelic with mutations in fibroblast growth factor receptor 2. Nat Genet 1994;8:275-9.
4. Jabs EW, Muller U, Li X, Ma L, Luo W, Haworth IS, Klisak I, Sparkes R, Warman ML, Mulliken JB et al. A mutation in the homeodomain of the human MSX2 gene in a family affected with autosomal dominant craniosynostosis. Cell 1993;75: 443-50.
5. Ma L, Golden S, Wu L, Maxson R. The molecular basis of Bostontype craniosynostosis: the Pro148 - >His mutation in the N-terminal arm of the MSX2 homeodomain stabilizes DNA binding without altering nucleotide sequence preferences. Hum Molec Genet 1996;5:1915-20.
6. Meyers GA, Day D, Goldberg R, Daentl DL, Przylepa KA, Abrams LJ, Graham JM JR, Feingold M, Moeschler JB, Rawnsley E, Scott AF, Jabs EW. FGFR2 exon IIIa and IIIc mutations in Crouzon, Jackson-Weiss, and Pfeiffer syndromes: evidence for missense changes, insertions, and a deletion due to alternative RNA splicing. Am J Hum Genet 1996;58:491-8.
7. Muenke M, Schell U, Hehr A, Robin NH, Losken HW, Schinzel A, Pulleyn LJ, Rutland P, Reardon W, Malcolm S et al. A common mutation in the fibroblast growth factor receptor 1 gene in Pfeiffer syndrome. Nat Genet; 1994;8:269-74.
8. Reardon W, Winter RM, Rutland P, Pulleyn LJ, Jones BM, Malcolm S. Mutations in the fibroblast growth factor receptor 2 gene cause Crouzon syndrome. Nat Genet 1994;8:98-103.
9. Wilkie AO, Slaney SF, Oldridge M, Poole MD, Ashworth GJ, Hockley AD, Hayward RD, David DJ, Pulleyn LJ, Rutland P et al. Apert syndrome results from localized mutations of FGFR2 and is allelic with Crouzon syndrome. Nat Genet 1995;9: 165-72.
10. Opperman LA. Sutures as intramembranous bone growth sites. Dev Dynam 2000;219:472-485.
11. Galvin BD, Hart KC, Meyer AN, Webster MK, Donoghue DJ. Constitutive receptor activation by Crouzon syndrome mutations in fibroblast growth factor receptor (FGFR) 2 and FGFR2/Neu chimeras. Proc Nat Acad Sci (USA) 1996;93:7894-9.
12. Anderson J, Burns HD, Enriquez-Harris P, Wilkie AOM, Heath JK. Apert syndrome mutations in fibroblast growth factor receptor 2 exhibit increased affinity for FGF ligand. Hum Molec Genet 1998;7:1475-83.
13. Kim HJ, Rice DP, Kettunen PJ, Thesleff I. FGF-, BMP- and Shhmediated signalling pathways in the regulation of cranial suture morphogenesis and calvarial bone development. Development 1998;125:1241-51.
14. Opperman LA, Adab K, Gakunga PT. TGF-B2 and TGF-B3 regulate fetal rat cranial suture morphogenesis by regulating rates of cell proliferation and apoptosis. Dev Dynam 2000;219:237-47.
15. Opperman LA, Nolen AA, Ogle RC. TGF-beta 1, TGF-beta 2, and TGF-beta 3 exhibit distinct patterns of expression during cranial suture formation and obliteration in vivo and in vitro. J Bone Min Res 1997b;12:301-10.
16. Roth DA, Longaker MT, McCarthy JG, Rosen DM, McMullen HF, Levine JP, Sung J, Gold LI. Studies in cranial suture biology: Part I. Increased immunoreactivity for TGF-beta isoforms (beta 1, beta 2, and beta 3) during rat cranial suture fusion. J Bone Min Res 1997b;12:311-21.
17. Centrella M, Ji C, Casinghino S, McCarthy TL. Rapidux in transforming growth factor-beta receptors on bone cells. J Biol Chem 1996;271:18616-22.
18. Roth DA, Gold LI, Han VK, McCarthy JG, Sung JJ, Wisoff JH, Longaker MT. Immunolocalization of transforming growth factor beta 1, beta 2, and beta 3 and insulin-like growth factor I in premature cranial suture fusion. Plast Reconstr Surg 1997a;99:300-9.
19. Mehrara BJ, Steinbrech DS, Saadeh PB, Gittes GK, Longaker MT. Expression of high-affinity receptors for TGF-beta during rat cranial suture fusion. Ann Plast Surg 1999;42:502-8.
20. Chong SL, Mitchell R, Moursi A, Winnard P, Losken HW, Ozerdem O, Keeler K, Opperman LA, Siegel MI, Mooney MP. Rescue of coronal suture synostosis with TGF-B3 in craniosynostotic rabbits. J Dental Res 2001;80:89.
21. Cooper GM, Sayne JR, Williams A, Moursi A, Opperman LA. TGFB3 in collagen gels rescues rat posterior frontal sutures from fusion in vivo. J Dent Res 2001;80:229.
22. Cheifetz S, Hernandez H, Laiho M, Ten Dijke P, Iwata KK, Massague J. Distinct transforming growth factor-beta (TGF-beta) receptor subsets as determinants of cellular responsiveness to three TGF-beta isoforms. J Biol Chem 1990;265:20533-8.
23. Opperman LA, Chhabra A, Cho RW, Ogle RC. Cranial suture obliteration is induced by removal of transforming growth factor (TGF) -beta 3 activity and prevented by removal of TGF-beta 2 activity from fetal rat calvaria in vitro. J Craniofac Genet Dev Biol 1999;19:164-73.
24. Opperman LA, Chhabra A, Nolen AA, Bao Y, Ogle RC. Increased cell proliferation and altered collagen production precede rat cranial suture fusion in vitro. Mol Biol Cell 1997a;8:329a.
25. Opperman LA, Chhabra A, Nolen AA, Bao Y, Ogle RC. Dura mater maintains rat cranial sutures in vitro by regulating suture cell proliferation and collagen production. J Craniofac Genet Dev Biol 1998;18:150-8.
26. Opperman LA, Passarelli RW, Morgan EP, Reintjes M, Ogle RC. Cranial sutures require tissue interactions with dura mater to resist osseous obliteration in vitro. J Bone Min Res 1995;10:1978-87.
27. Opperman LA, Passarelli RW, Nolen AA, Gampper TJ, Lin KY, Ogle RC. Dura mater secretes soluble heparin-binding factors required for cranial suture morphogenesis. In Vitro Cell Dev Biol 1996;32:627-32.
28. Horner A, Kemp P, Summers C, Bord S, Bishop NJ, Kelsall AW, Coleman N, Compston JE. Expression and distribution of transforming growth factor-beta isoforms and their signaling receptors in growing human bone. Bone 1998;23:95-102.
29. Kabasawa Y, Ejiri S, Matsuki Y, Hara K, Ozawa H. Immunoreactive localization of transforming growth factor-beta type II receptorpositive cells in rat tibiae. Bone 1998;22:93-8.
30. Iseki S, Wilkie AO, Morriss-Kay GM. Fgfr1 and Fgfr2 have distinct differentiation- and proliferation-related roles in the developing mouse skull vault. Development 1999;126:5611-20.
31. Frolik CA, Wakefield LM, Smith DM, Sporn MB. Characterization of a membrane receptor for transforming growth factor-beta in normal rat kidney fibroblasts. J Biol Chem 1984;259:10995-11000.
32. Wakefield LM, Smith DM, Masui T, Harris CC, Sporn MB. Distribution and modulation of the cellular receptor for transforming growth factor-beta. J Cell Biol 1987;105:965-75.
33. Meyers GA, Orlow SJ, Munro IR, Przylepa KA, Jabs EW. Fibroblast growth factor receptor 3 (FGFR3) transmembrane mutation in Crouzon syndrome with acanthosis nigricans. Nat Genet 1995;11:462-4.
34. Muenke M, Gripp KW, McDonald-McGinn DM, Gaudenz K, Whitaker LA, Bartlett SP, Markowitz RI, Robin NH, Nwokoro N, Mulvihill JJ, Losken HW, Mulliken JB, Guttmacher AE, Wilroy RS, Clarke LA, Hollway G, Ades LC, Haan EA, Mulley JC, Cohen MM JR, Bellus GA, Francomano CA, Moloney DM, Wall SA, Wilkie AO et al. A unique point mutation in the fibroblast growth factor receptor 3 gene (FGFR3) defines a new craniosynostosis syndrome. Am J Hum Genet 1997;60:555-64.
35. El Ghouzzi V, Le Merrer M, Perrin-Schmitt F, Lajeunie E, Benit P, Renier D, Bourgeois P, Bolcato-Bellemin AL, Munnich A, Bonaventure J. Mutations of the TWIST gene in the Saethre-Chotzen syndrome. Nat Genet 1997;15:42-6.
36. Howard TD, Paznekas WA, Green ED, Chiang LC, Ma N. Ortiz De Luna RI, Garcia Delgado C, Gonzalez-Ramos M, Kline AD, Jabs EW. Mutations in TWIST, a basic helix-loop-helix transcription factor, in Saethre-Chotzen syndrome. Nat Genet 1997;15:36-41.
37. Zhou G, Chen Y, Zhou L, Thirunavukkarasu K, Hecht J, Chitayat D, Gelb BD, Pirinen S, Berry SA, Greenberg CR, Karsenty G, Lee B. CBFA1 mutation analysis and functional correlation with phenotypic variability in cleidocranial dysplasia. Hum Molec Genet 1999;8:2311-6.
38. Zhou Y-X, Xu X, Chen L, Li C, Brodie SG, Deng C-X. A Pro250Arg substitution in mouse Fgfr1 causes increased expression of Cbfa1 and premature fusion of calvarial sutures. Hum Molec Genet; 2000;9:2001-8.
39. Ji C, Casinghino S, Chang DJ, Chen Y, Javed A, Ito Y, Hiebert SW, Lian JB, Stein GS, McCarthy TL, Centrella M. CBFa (AML/PEBP2)-related elements in the TGF-beta type I receptor promoter and expression with osteoblast differentiation. J Cell Biochem 1998;69:353-63.